Pathoma Chapter 6: Part 2 Flashcards
What are myeloproliferative disorders (MPDs)?
neoplastic proliferation of mature cells of myeloid lineage
When do MPDs usually present?
late adulthood (50-60 y/o)
T or F. in MPDs cells of all myeloid lineages are increased.
T. Subtypes are classified based on the major cell type produced
Complications with MPDs include what?
- increased risk for hyperuricemia and gout due to high turnover of cells
- progression to marrow fibrosis or transformation to acute leukemia
What are some types of MPDs?
- chronic myeloid leukemia (CML)
- polycythemia vera (PV)
- essential thrombocytopenia
- myelofibrosis
What is CML caused by?
neoplastic proliferation of mature myeloid cells, especially granulocytes and their precursors
What is characteristically increased in CML?
basophils
Cause of CML?
t(9,22) Philadelphia chromosome which generates a BCR-ABL fusion protein with increased tyrosine kinase activity
Treatment for CML?
Imatinib, which blocks tyrosine kinase activity
Progression of CML?
-splenomegaly common and enlarging spleen suggest progression to accelerated phase of the disease and can transform to acute leukemia (ALL 1/3 of times and AML 2/3 of times- because mutation is in a pluripotent stem cell) shortly after
How is CML distinguished from a leukomoid reaction (reactive neutrophilic leukocytosis)?
1) Negative leukocyte alkaline phosphatase (LAP stain) in CML
2) Increased basophils in CML
3) t(9,22) presence
What is polycythemia vera (PV) caused by?
proliferation of mature myeloid cells- especially RBCS (granulocytes and platelets also increased)
Clinical symptoms of PV?
due to hyper viscosity of blood:
1) blurry vision and headache
2) flushed face due to congestion
3) itching after bathing (histamine mediated)
4) risk of venous thrombosis
Treatment for PV?
1) phlebotomy
2) hydroxyurea
without treatment, death usually occurs in 1 year
How is PV distinguished from reactive polycythemia?
1) In PV, EPO levels are decreased and SaO2 is normal
2) In reactive polycythemia, SaO2 is low and EPO is increased
What is essential thrombocythemia (ET) caused by?
neoplastic proliferation of mature myeloid cells, especially platelets
PV and ET (and myelofibrosis sometimes) are both associated with what?
Jak2 kinase mutation
T or F. ET commonly progresses to acute leukemia
F, hardly ever progress and no significant risk for hyperuricemia or gout
What is myelofibrosis caused by?
neoplastic proliferation of mature myeloid cells, especially megakaryocytes
What is the root cause of marrow fibrosis in myelofibrosis?
megakaryocytes produce excess platelet- derived growth factor (PDGF)